Caroline Woodworth, Vice President in General Atlantic’s London office, was named in Financial News’ list of the 25 rising stars in European private equity. Caroline focuses on General Atlantic’s investments in the Financial Services sector and was recognized for her contributions to the firm’s investment in Deutsche Börse’s Index and Portfolio Risk/Analytics Business, Greensill, and the IPO of Network International, amongst other personal and career achievements.
General Atlantic, a leading global growth equity firm, announced today that Pedro Parente will join the firm as Chairman of Brazil, as of June 18, 2019.
PathAI Secures $60M in Series B Funding Led by General Atlantic and Existing Investor General Catalyst
PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by new investor General Atlantic, a leading global growth equity firm, with strong participation from General Catalyst and other existing investors. The new capital will fuel PathAI’s continued expansion as the company seeks to advance the medical discipline of pathology. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors as the company advances its mission of offering faster, safer, and more powerful solutions for the diagnosis and sub-typing of diseases like cancer.
General Atlantic, a leading global growth equity firm, announced today that Michael Gosk, former Vice President and Chief Tax Officer at General Electric (“GE”) has joined the firm as an Operating Partner. Based in New York, Mr. Gosk will provide expertise and strategic counsel to the firm’s investment team and portfolio companies, with a particular focus on financial operations and tax.
General Atlantic Invests in Deutsche Börse Index and Portfolio Risk/Analytics Business; Combines DB’s Existing Index Provider with Axioma, Inc.
Deutsche Börse AG (Deutsche Börse) and Axioma, Inc. (Axioma) announced that Axioma has agreed to be acquired by Deutsche Börse for US$850 million cash and debt free (around US$820 million equity value) and will be combined with Deutsche Börse’s index businesses (STOXX® and DAX®) valued at €2.6 billion.
Rubicon Research Pvt Ltd (“Rubicon”), a global leader in innovative pharmaceutical product development, announced today that General Atlantic has become a significant shareholder in the company. General Atlantic, a leading global growth equity firm, is committing up to $100 million of primary capital and has acquired the stake held by Rubicon’s existing private equity shareholders. All other existing shareholders continue to maintain their shareholding in the company.
Doctolib offers doctors and hospitals a software solution with a full range of services to help improve the efficiency of their operations, provide their patients with a more seamless experience, find new patients, and collaborate with other doctors. Doctolib offers more transparent access to healthcare for patients, by providing a full-suite of online services to manage their health. Doctolib allows patients to find nearby healthcare professionals, book / manage appointments online 24/7, have remote medical consultations via video and receive a digital prescription in their online account.
London & Amsterdam — March 11, 2019 — General Atlantic, a leading global growth equity firm, today announced that Loek van den Boog, former Chairman of Mendix and Myriad, has joined the firm as a Special Advisor and Chairman of General Atlantic Netherlands. Mr. Van den Boog returns to the firm having previously supported the firm as Special Advisor between 1996 and 2004. During his prior tenure at General Atlantic, he served on a number of portfolio company boards, including Global Collect and Patni Computer Systems. Upon his return, he is expected to leverage his software and technology expertise and expansive network to provide strategic support and advice to the firm’s investment teams and portfolio companies.